hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06352034 id: Empathy Training for Students briefTitle: Empathy Training for Future Mental Health Practitioners in University Students overallStatus: NOT_YET_RECRUITING date: 2024-03-30 date: 2024-04-30 date: 2024-10-01 date: 2024-04-08 date: 2024-04-08 name: Peking University class: OTHER briefSummary: This study aims to investigate the efficacy of empathy training for future psychological counselors in university students. The training contains 5 sessions of psychoeducation, three-role group exercises, and Q\&A. Self-reported, listener-reported, and observer-reported measurements will be applied for empathy assessment. conditions: Empathy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 50 type: ESTIMATED name: Empathy Training measure: Change from counseling duration measure: Change from Baseline of 12-Item Version of the Barrett-Lennard Relationship Inventory measure: Change from consultation willingness question inquiry measure: Change from morphed emotion perception task measure: Change from Baseline of the Measure of Empathy Scale measure: Change from Baseline of the Emotion Perception Scale measure: Change from Baseline of the Peking Alexithymia Scale measure: Change from Baseline of the Patient Health Questionnaire measure: Change from Baseline of the Generalized Anxiety Disorder Scale measure: Change from Baseline of the Peking Irritability Scale measure: Change from Baseline of the the Fatigue Assessment Scale measure: Change from Baseline of the the Patient Health Questionnaire measure: Change from Baseline of the Cognitive-Emotion Regulation Questionnaire measure: Change from Baseline of the Difficulties in Emotion Regulation Scale measure: Change from Baseline of the the Satisfaction with Life Scale measure: Change from Baseline of the the Subjective Happiness Scale measure: Change from Baseline of the Connor-Davidson Resilience Scale sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Peking University city: Peking state: Beijing zip: 100871 country: China lat: 39.9075 lon: 116.39723 hasResults: False
nctId: NCT06352021 id: KAHRİMAN İlknur briefTitle: The Effect of Distraction With a Kaleidoscope on the Level of Perceived Pain During Blood Sampling in Children overallStatus: COMPLETED date: 2019-05-30 date: 2019-06-30 date: 2019-06-30 date: 2024-04-08 date: 2024-04-08 name: İlknur KAHRİMAN class: OTHER briefSummary: This experimental study aimed to determine the effect of distracting children with a kaleidoscope during blood sampling on their perception of pain during the procedure and to increase and improve the quality of evidence for the effectiveness of these methods across different populations and cultures.
Hypothesis 1 (H1): There is a difference between the pain scores of the kaleidoscope group and the control group during blood sampling. conditions: Pain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 60 type: ACTUAL name: kaleidoscope measure: The Wong-Baker Pain Scale sex: ALL minimumAge: 7 Years maximumAge: 12 Years stdAges: CHILD facility: Karadeniz Technical University Health Application and Research Center Farabi Hospital city: Trabzon zip: 61080 country: Turkey lat: 41.005 lon: 39.72694 hasResults: False
nctId: NCT06352008 id: Zhansheng Jiang briefTitle: To Evaluate the Efficacy and Safety of Anrotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer overallStatus: NOT_YET_RECRUITING date: 2024-06-01 date: 2025-06-01 date: 2026-06-01 date: 2024-04-08 date: 2024-04-08 name: Tianjin Medical University Cancer Institute and Hospital class: OTHER briefSummary: To explore the effectiveness of anrotinib hydrochloride capsule in postoperative non-pCR non-small cell lung cancer patients with adjuvant intensive therapy conditions: Event-free Lifetime studyType: INTERVENTIONAL phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 64 type: ESTIMATED name: Anlotinib measure: EFS sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Tianiin Medical University Cancer Institute & Hospital city: Tianjin country: China role: CONTACT phone: +008618526812877 lat: 39.14222 lon: 117.17667 hasResults: False
nctId: NCT06351995 id: KOR-19-22 briefTitle: Neostigmine and Glycopyrrolate by Iontophoresis overallStatus: ACTIVE_NOT_RECRUITING date: 2020-11-06 date: 2022-10-25 date: 2025-01-01 date: 2024-04-08 date: 2024-04-08 name: James J. Peters Veterans Affairs Medical Center class: FED briefSummary: To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis. conditions: Spinal Cord Injuries conditions: Constipation conditions: Fecal Incontinence conditions: Neurogenic Bowel studyType: INTERVENTIONAL phases: PHASE3 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 6 type: ACTUAL name: Combination of Neostigmine and Glycopyrrolate name: I-Box by Dynatronics measure: Presence or absence of bowel evacuation measure: Time to bowel evacuation measure: Stool Consistency measure: Stool Quantity measure: Presence or absence of headache, dry mouth, muscle twitching and abdominal cramps. sex: ALL minimumAge: 18 Years maximumAge: 89 Years stdAges: ADULT stdAges: OLDER_ADULT facility: James J. Peters Veterans Affairs Medical Center city: Bronx state: New York zip: 10468 country: United States lat: 40.84985 lon: -73.86641 hasResults: False
nctId: NCT06351982 id: 211123PER3-3-2 briefTitle: Treatment Of Shallow Periodontal Pockets 4-6mm Using AIRFLOW Prophylaxis Master Device With Erythritol vs Manual Scalers overallStatus: RECRUITING date: 2024-03-01 date: 2025-06-01 date: 2026-01-01 date: 2024-04-08 date: 2024-04-08 name: Cairo University class: OTHER briefSummary: Periodontitis is a chronic condition associated with the inflammatory destruction of the periodontal tissues ultimately leading to tooth loss. Clinically, it is identified by key features such as clinical attachment loss (CAL), bleeding upon probing (BOP), and an increase in probing pocket depth (PPD), and/or gingival recession. Periodontitis is mediated by polymicrobial dysbiosis with keystone pathogens affecting the virulence of the entire biofilm community. The removal of this biofilm and its retention factors is the ultimate goal of clinical treatment and oral measures applied. The elimination of the biofilm has traditionally been achieved with the use of either hand instruments or power driven devices. Promoting periodontal health or diminishing bacterial presence and calculus buildup on teeth can be accomplished with the same efficacy whether using manual scalers and curettes or ultrasonic scaling instruments.
The aim of this study is to evaluate changes in probing depth clinically, Bleeding on probing, Clinical attachment level, Plaque index, Calculus index, Patient pain/discomfort, Patient satisfaction, Cost effectiveness, Treatment time and Number of pockets closed after using AIRFLOW® Prophylaxis Master device with erythritol powder. conditions: Periodontal Pocket conditions: Periodontitis conditions: Gingival Diseases conditions: Gingival Bleeding studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 46 type: ESTIMATED name: Electro Medical Systems AIRFLOW® Prophylaxis Master Device name: Hand and ultrasonic scalers and curettes measure: Change in probing pocket depth measure: Bleeding On Probing measure: Clinical Attachment Level measure: Plaque index measure: Calculus index measure: Patient pain/discomfort measure: Patient satisfaction measure: Cost effectiveness measure: Treatment time measure: Number of healed pockets sex: ALL minimumAge: 16 Years maximumAge: 80 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Faculty of Dentistry, Cairo University status: RECRUITING city: Cairo country: Egypt lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06351969 id: Ms 9-12-2023 briefTitle: Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss overallStatus: RECRUITING date: 2023-12-21 date: 2024-12 date: 2024-12 date: 2024-04-08 date: 2024-04-08 name: Benha University class: OTHER briefSummary: Aim of the Work is To determine the significance of the placental thickness and the thickness of the uterine muscle layer at placenta attachment in the prediction of postpartum hemorrhage and to evaluate both of them as as parameters for identifying high-risk patients. conditions: Post Partum Hemorrhage studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 150 type: ESTIMATED measure: Evaluating Placental Thickness in cm and Thickness of Uterine Muscle in cm at Placenta Attachment in Prediction of Postpartum Blood Loss sex: FEMALE minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Benha Univeristy status: RECRUITING city: Banhā country: Egypt name: Ashraf Ismail mohamed, professor role: CONTACT phone: +201119709696 lat: 30.45906 lon: 31.17858 hasResults: False
nctId: NCT06351956 id: Arrhythmias in Septic Patients briefTitle: New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes. overallStatus: NOT_YET_RECRUITING date: 2024-04-20 date: 2026-04-20 date: 2026-12-30 date: 2024-04-08 date: 2024-04-08 name: Assiut University class: OTHER briefSummary: New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes conditions: Cardiac Arrhythmia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 72 type: ESTIMATED measure: Risk Factors of cardiac arrhythmias in septic patients in CU. measure: Fates of cardiac arrhythmia. measure: The frequent type of arrhythmias. measure: Mortality rate due to new onset arrhythmia. sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06351943 id: ImageDB pilot briefTitle: Proximal Femur Image Database Validation overallStatus: ACTIVE_NOT_RECRUITING date: 2021-05-01 date: 2024-10-01 date: 2025-06-30 date: 2024-04-08 date: 2024-04-08 name: AO Innovation Translation Center class: OTHER name: University of Turin, Italy briefSummary: The AO@AI Turin project is a collaborative project with a Turin group and the AO (Arbeitsgemeinschaft für Osteosynthesefragen, or in English, Association for the Study of Internal Fixation) foundation. An Image database (DB) has been built to host AP pelvic radiographs ready for artificial intelligence (AI) development.
The goal of this project is to determine the agreement between the Turin annotation of fracture status and the annotation from an external group of AO expert surgeons for a random subset of the Turin images. conditions: Proximal Femoral Fracture studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: CROSS_SECTIONAL count: 2932 type: ESTIMATED name: Fracture classification annotations provided by the Turin group name: Fracture classification annotations provided by the AO expert surgeon group measure: Annotations of fracture status of the image measure: In case of fracture, Arbeitsgemeinschaft für Osteosynthesefragen (AO, in English, Association for the Study of Internal Fixation)/Orthopedic Trauma Association (OTA) classification: Type measure: In case of fracture, AO/OTA classification: Group measure: In case of fracture, AO/OTA classification: Subgroup measure: In case of fracture, AO/OTA classification: Qualifier for 31A1.1 measure: In case of fracture, AO/OTA classification: Qualifier for 31B2 sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: AO Foundation city: Dübendorf zip: 8600 country: Switzerland lat: 47.39721 lon: 8.61871 hasResults: False
nctId: NCT06351917 id: LEVEXE briefTitle: Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-04-01 date: 2025-05-01 date: 2024-04-08 date: 2024-04-10 name: RDC Clinical Pty Ltd class: INDUSTRY briefSummary: This is a randomised, double-blind, placebo controlled, 2 arm parallel clinical trial to evaluate the effect of topical PlexoZome® Levagen® spray on relief of post exercise knee joint pain in healthy adults compared to placebo over 4 weeks duration. conditions: Knee Joint Pain studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 80 type: ESTIMATED name: PlexoZome® Levagen® topical spray solution name: Placebo topical spray solution measure: Joint pain measure: Time to pain relief measure: Number of Adverse Events measure: Severity of Adverse Events measure: Rescue medication use sex: ALL minimumAge: 20 Years stdAges: ADULT stdAges: OLDER_ADULT facility: RDC Clinical Pty Ltd city: Brisbane state: Queensland zip: 4006 country: Australia name: Amanda Rao, PhD role: CONTACT phone: +61 414 488 559 email: amanda@rdcglobal.com.au name: David Briskey, PhD role: CONTACT phone: +61 421 784 077 email: david@rdcglobal.com.au name: Amanda Rao, PhD role: PRINCIPAL_INVESTIGATOR lat: -27.46794 lon: 153.02809 hasResults: False
nctId: NCT06351904 id: RAG-01-01 briefTitle: A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy overallStatus: RECRUITING date: 2024-04-03 date: 2025-06-30 date: 2025-08-31 date: 2024-04-08 date: 2024-04-16 name: Ractigen Therapeutics. class: OTHER briefSummary: This is an open label, multi-center study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of RAG-01 in patients with NMIBC who have failed BCG therapy. conditions: Non-Muscle-Invasive Bladder Cancer (NMIBC) studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 15 type: ESTIMATED name: RAG-01 measure: Safety and tolerability of RAG-01 in patients with non-muscle-invasive bladder cancer (NMIBC) measure: Maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) of RAG-01 sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: GenesisCare North Shore status: RECRUITING city: St Leonards state: New South Wales zip: 2065 country: Australia name: Laurence Krieger, MBCHB role: CONTACT phone: +61 2 8037 4100 email: laurence_krieger@hotmail.com lat: -33.82344 lon: 151.19836 hasResults: False
nctId: NCT06351891 id: SHARE2402 briefTitle: Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-12 date: 2024-12 date: 2024-04-08 date: 2024-04-08 name: Qilu Hospital of Shandong University class: OTHER briefSummary: The researchers collected untreated H. pylori positive patients from outpatient clinics. Subjects were randomly assigned to receive either 14 days of bismuth quadruple therapy with cefuroxime and tetracycline or 14 days of bismuth quadruple therapy with cefuroxime and levofloxacin for Helicobacter pylori eradication. After 6 weeks of treatment, subjects underwent another 13C urea breath test. Eradication rates, adverse reaction rates and patient compliance were calculated. conditions: Helicobacter Pylori Infection studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 248 type: ESTIMATED name: 14-day bismuth quadruple regimen containing cefuroxime and tetracycline name: 14-day bismuth quadruple regimen containing cefuroxime and levofloxacin measure: Eradication rate measure: Rate of adverse reactions measure: Patient compliance sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Qilu Hospital of Shandong University city: Jinan state: Shandong zip: 250012 country: China name: Yueyue Li, MD,PhD role: CONTACT phone: 86-18560089751 email: lyynqj@162.com lat: 36.66833 lon: 116.99722 hasResults: False
nctId: NCT06351878 id: Pro00113559 briefTitle: TipTraQ Home Sleep Test Validation Study overallStatus: RECRUITING date: 2024-02-28 date: 2024-08-23 date: 2024-08-23 date: 2024-04-08 date: 2024-04-08 name: PranaQ Pte. Ltd. class: INDUSTRY briefSummary: A validation study has been designed to assess the performance of a home sleep test device, TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ device on their fingertip during a traditional sleep test, known as polysomnography (PSG), conducted in a sleep center. The performance of the device will then be evaluated by comparing the results from the TipTraQ system with those from the traditional sleep test. conditions: Obstructive Sleep Apnea studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: PROSPECTIVE count: 125 type: ESTIMATED measure: Apnea Hypopnea Index(AHI) measure: Oxygen Desaturation Index(ODI) measure: Total Sleep Time(TST) sex: ALL minimumAge: 20 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Duke University status: RECRUITING city: Durham state: North Carolina zip: 27705 country: United States name: Alexis Schuettke role: CONTACT phone: 919-668-2842 email: alexis.schuettke@duke.edu lat: 35.99403 lon: -78.89862 hasResults: False
nctId: NCT06351865 id: PHU/2023/21 briefTitle: Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent acronym: PRC overallStatus: RECRUITING date: 2024-03-07 date: 2024-09-19 date: 2024-10-31 date: 2024-04-08 date: 2024-04-09 name: Portsmouth Hospitals NHS Trust class: OTHER_GOV name: University of East Anglia briefSummary: Patient report complication data to our best knowledge has not been studied yet in electronic consent. This study is a feasibility study to assess whether patients will reliably report their complications, the quality of this reporting and whether the information provided in the consent form matches up to their experience. This data will then be used to improve the consent process and evaluate whether the Patient Initiated Follow Up (PIFU) model is effective or if it leads to underreporting of problems. conditions: Breast Cancer conditions: Complication of Surgical Procedure studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 50 type: ESTIMATED measure: Proportion of patients who respond to the feedback questionnaire measure: Final attrition rate measure: Quoted risks in the consent to the incidence of complications measure: Frequency of PRC and CRCs (Consent Form Reported Complications) measure: Understanding of consent measure: Language used in patient reported complications measure: Accuracy of potential complications measure: Participant preparation for surgery sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Queen Alexandra Hospital status: RECRUITING city: Portsmouth state: Hampshire zip: PO6 3LY country: United Kingdom name: Edward St John role: CONTACT phone: 02392286000 email: edward.stjohn@porthosp.nhs.uk lat: 50.79899 lon: -1.09125 hasResults: False
nctId: NCT06351852 id: 1678243 briefTitle: Transdermal Administration by a Novel Wireless Iontophoresis Device overallStatus: RECRUITING date: 2022-03-22 date: 2025-02-15 date: 2025-02-15 date: 2024-04-08 date: 2024-04-08 name: James J. Peters Veterans Affairs Medical Center class: FED briefSummary: Persons with spinal cord injury (SCI) have neurogenic bowel disorders which is associated with significant morbidity. The negative impact of bowel complications is often at the top of the list of problems reported by persons with SCI. Despite the magnitude of the problem of bowel dysfunction in persons with SCI, and the associated reduction in quality of life, this condition has yet to be effectively treated. The investigators have developed a novel dual drug combination to elicit a safe and predictable bowel evacuation (BE).
The ability to move the bowel contents along to the rectum was severely impaired primary because of poor gut contractions on the left side of the colon, as shown by our team of investigators. To address this problem, a dual medication combination (neostigmine and glycopyrrolate) was developed that safely and predictably caused the bowel to empty after delivering these drugs into a vein (intravenously) or into the muscle bed (intramuscularly). Because no one likes needles, and because of the practical limits of administering medications on a routine basis by the use of needles, especially in persons with SCI because of their other health considerations, the investigators have devised a new approach: driving these medications across the skin and into the circulation of the body by applying an electrical current that is too small to feel (iontophoresis).
The proposed research project to determine the safety of positively charged compounds (e.g., vitamin B12, NEO, and GLY) administered transcutaneously by the prototype wireless ION device and to compare the pharmacokinetic profiles of transcutaneous administration of NEO and GLY by the wireless ION device to a commercially available wired ION device. The potential administration of any number of other positively charged agents by this wireless prototype may be a clinically relevant outcome of this work. The ability to use a wireless ION device is far more practical for patients to use, especially those with SCI, which will permit the self-administration of these agents in the home setting to induce a bowel evacuation. conditions: Spinal Cord Injuries conditions: Constipation conditions: Fecal Incontinence conditions: Neurogenic Bowel studyType: INTERVENTIONAL phases: EARLY_PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 6 type: ESTIMATED name: Combination of Neostigmine and Glycopyrrolate name: I-Box by Dynatronics measure: Presence or absence of bowel evacuation measure: Time to bowel evacuation measure: Stool Consistency measure: Stool Quantity measure: Presence or absence of headache, dry mouth, muscle twitching and abdominal cramps sex: ALL minimumAge: 18 Years maximumAge: 89 Years stdAges: ADULT stdAges: OLDER_ADULT facility: James J. Peters Veterans Affairs Medical Center status: RECRUITING city: Bronx state: New York zip: 10468 country: United States name: Christopher P Cardozo, MD role: CONTACT phone: 718-584-9000 phoneExt: 1828 email: christopher.cardozo@va.gov lat: 40.84985 lon: -73.86641 hasResults: False
nctId: NCT06351839 id: 2024/500457(REK) briefTitle: Sleep Well Despite Persistent Pain Symptoms acronym: Sleep-Well overallStatus: NOT_YET_RECRUITING date: 2024-10 date: 2026-12 date: 2027-12 date: 2024-04-08 date: 2024-04-08 name: University of Tromso class: OTHER name: University Hospital of North Norway name: Diakonhjemmet Hospital briefSummary: Background: The prevalence of comorbid insomnia is 8-10 times higher in patients with chronic pain than in the general population. Insomnia adds a considerable burden as it worsens the quality of life, restoration and repair, mental health and pain symptoms. Since pain and sleep problems are mutually reinforcing, improvements in sleep may have beneficial effects on pain. Unfortunately, the customary use of sleep medication (TAU: treatment-as-usual) often yields short-lived plus side effects. The "Sleep-Well" intervention examines if a group-based intervention program focusing on sleep literacy, sleep restriction, stimulus control and metacognitive therapy modules may perform better than TAU in improving patients' insomnia and sleep quality.